In SARS-CoV-2 infection, the increased level of VEGF leads to high permeability, edema and tissue injury, which triggers the pathogenesis of acute lung injury in patients with COVID-19 (Teuwen et al., 2020; Wu and McGoogan, 2020). Here, VEGFA is linked to COVID-19.